Anthera Pharmaceuticals Inc (ANTH)
0.00
USD |
OTCM |
May 06, 16:00
Anthera Pharmaceuticals Cash from Financing (Quarterly): 14.91M for March 31, 2018
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2018 | 14.91M |
| December 31, 2017 | 2.38M |
| September 30, 2017 | 1.123M |
| June 30, 2017 | 0.612M |
| March 31, 2017 | 14.14M |
| December 31, 2016 | 0.315M |
| September 30, 2016 | 19.02M |
| June 30, 2016 | 2.612M |
| March 31, 2016 | 1.63M |
| December 31, 2015 | 0.642M |
| September 30, 2015 | 29.01M |
| June 30, 2015 | 0.018M |
| March 31, 2015 | 45.63M |
| December 31, 2014 | -7.045M |
| September 30, 2014 | -0.697M |
| June 30, 2014 | 0.033M |
| March 31, 2014 | 0.003M |
| December 31, 2013 | -0.415M |
| September 30, 2013 | 0.033M |
| Date | Value |
|---|---|
| June 30, 2013 | 3.214M |
| March 31, 2013 | 40.28M |
| December 31, 2012 | -2.251M |
| September 30, 2012 | 33.37M |
| June 30, 2012 | 0.016M |
| March 31, 2012 | 0.125M |
| December 31, 2011 | 0.083M |
| September 30, 2011 | -0.504M |
| June 30, 2011 | 54.10M |
| March 31, 2011 | 24.74M |
| December 31, 2010 | -0.188M |
| September 30, 2010 | 29.28M |
| June 30, 2010 | 2.068M |
| March 31, 2010 | 56.37M |
| December 31, 2009 | 3.029M |
| September 30, 2009 | 10.02M |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.026M |
| Palatin Technologies Inc | 4.974M |
| iBio Inc | 4.005M |
| Theriva Biologics Inc | -1.457M |
| Oragenics Inc | -0.1806M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.381M |
| Cash from Investing (Quarterly) | 0.358M |